Clinical management of renal artery fibromuscular dysplasia: Temporal trends and outcomes

Journal of Hypertension

Volumn 32, Issue 12, 2014, Pages 2433-2438

  Giavarini, Alessandra ^a,b   Savard, Sébastien ^a,c   Sapoval, Marc ^a,d   Plouin, Pierre François ^a,d   Steichen, Olivier ^e,f,g  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b UNIVERSITY OF MILAN   (Italy)

^c LAVAL UNIVERSITY   (Canada)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e HÔPITAL TENON   (France)

^f SORBONNE UNIVERSITÉ   (France)

^g Laboratoire d'Informatique Médicale et d'Ingénierie des Connaissances pour la e Santé   (France)

Author keywords

Balloon angioplasty; Fibromuscular dysplasia; Outcomes assessment; Renal artery obstruction; Vascular surgical procedures

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; ANGIOPLASTY; ARTERY SURGERY; ARTICLE; BLOOD PRESSURE; COMPARATIVE EFFECTIVENESS; CONSERVATIVE TREATMENT; CONTROLLED STUDY; FEMALE; FIBROMUSCULAR DYSPLASIA; GROUPS BY AGE; HUMAN; HYPERTENSION; KIDNEY ARTERY STENOSIS; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVASCULARIZATION; SEX DIFFERENCE; AGED; ANGIOGRAPHY; FRANCE; KIDNEY; KIDNEY ARTERY; MIDDLE AGED; PATHOPHYSIOLOGY; RADIOGRAPHY; RENAL ARTERY OBSTRUCTION; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VASCULARIZATION;

ADULT; AGED; ANGIOGRAPHY; ANGIOPLASTY; FEMALE; FIBROMUSCULAR DYSPLASIA; FRANCE; HUMANS; HYPERTENSION; KIDNEY; MALE; MIDDLE AGED; RENAL ARTERY; RENAL ARTERY OBSTRUCTION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84927796797     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000349     Document Type: Article

References (17)

1. Slovut DP, Olin JW. Fibromuscular dysplasia. N Engl J Med 2004; 350:1862-1871
2. Plouin PF, Perdu J, La Batide-Alanore A, Boutouyrie P, Gimenez- Roqueplo A-P, Jeunemaitre X. Fibromuscular dysplasia. Orphanet J Rare Dis 2007; 2:28.
3. Olin JW, Froehlich J, Gu X, Bacharach JM, Eagle K, Gray BH, et al. The United States registry for fibromuscular dysplasia: results in the first 447 patients. Circulation 2012; 125:3182-3190.
4. Savard S, Steichen O, Azarine A, Azizi M, Jeunemaitre X, Plouin PF. Association between 2 angiographic subtypes of renal artery fibromuscular dysplasia and clinical characteristics. Circulation 2012; 126:3062-3069.
5. Olin JW. Is fibromuscular dysplasia a single disease? Circulation 2012; 126:2925-2927.
6. Persu A, Giavarini A, Touzé E, Januszewicz A, Sapoval M, Azizi M, et al., On behalf of the ESH Working Group 'Hypertension and the Kidney'. European consensus on the diagnosis and management of fibromuscular dysplasia. J Hypertens 2014; 32:1367-1378.
7. Trinquart L, Mounier-Vehier C, Sapoval M, Gagnon N, Plouin PF. Efficacy of revascularization for renal artery stenosis caused by fibromuscular dysplasia: a systematic review and meta-analysis. Hypertension 2010; 56:525-532.
8. Savard S, Azarine A, Jeunemaitre X, Azizi M, Plouin PF, Steichen O. Association of smoking with phenotype at diagnosis and vascular interventions in patients with renal artery fibromuscular dysplasia. Hypertension 2013; 61:1227-1232.
9. La Batide-Alanore A, Chatellier G, Bobrie G, Fofol I, Plouin PF. Comparison of nurse-and physician-determined clinic blood pressure levels in patients referred to a hypertension clinic: implications for subsequent management. J Hypertens 2000; 18:391-398.
10. Earley A, Miskulin D, Lamb EJ, Levey AS, Uhlig K. Estimating equations for glomerular filtration rate in the era of creatinine standardization: a systematic review. Ann Intern Med 2012; 156:785-795.
11. Barral X, Joffre F, Mousseaux E, Persu A, Plouin PF, Touzé E, et al. Dysplasie fibromusculaire symptomatique chez l'adulte. Protocole national de diagnostic et de soins. Haute Autorité de Santé [Internet]. 2010. http://www.hassante.fr/portail/upload/docs/application/pdf/2011-03/ald-31-pnds-dfm-web.pdf.
12. Pannier-Moreau I, Grimbert P, Fiquet-Kempf B, Vuagnat A, Jeunemaitre X, Corvol P, Plouin PF. Possible familial origin of multifocal renal artery fibromuscular dysplasia. J Hypertens 1997; 15:1797-1801.
13. Willoteaux S, Faivre-Pierret M, Moranne O, Lions C, Bruzzi J, Finot M, et al. Fibromuscular dysplasia of the main renal arteries: comparison of contrast-enhanced MR angiography with digital subtraction angiography. Radiology 2006; 241:922-929.
14. Lüscher T, Keller H, Imhof H, Greminger P, Kuhlmann U, Largiadèr F, et al. Fibromuscular hyperplasia: extension of the disease and therapeutic outcome. Results of the University Hospital Zurich Cooperative Study on Fibromuscular Hyperplasia. Nephron 1986; 44:109-114.
15. Hägg A, Aberg H, Eriksson I, Lörelius LE, Mörlin C. Fibromuscular dysplasia of the renal artery: management and outcome. Acta Chir Scand 1987; 153:15-20.
16. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, et al. American Association for Vascular Surgery; Society for Vascular Surgery; Society for Cardiovascular Angiography and Interventions; Society for Vascular Medicine and Biology; Society of Interventional Radiology; ACC/AHA Task Force on Practice Guidelines Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease; American Association of Cardiovascularand Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; Vascular Disease Foundation. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006; 113:e463-e654.
17. Tendera M, Aboyans V, Bartelink ML, Baumgartner I, Clément D, Collet JP, et al. ESC Committee for Practice Guidelines. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J 2011; 32:2851-2906.